Suchergebnisse - "Vergé, Romain"

PubPharm (7)

1

Druggable redox pathways against M. abscessus in cystic fibrosis patient-derived airway organoids

enthalten in: bioRxiv.org | 2023

von Leon-Icaza, S. | Bagayoko, S. | Vergé, R. | +24

2

EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption

enthalten in: The Journal of experimental medicine | 2023

von Pinilla, M. | Mazars, R. | Vergé, R. | +19

CommentIn: J Exp Med. 2023 Oct 2;220(10):. - PMID 37642998

3

Druggable redox pathways against Mycobacterium abscessus in cystic fibrosis patient-derived airway organoids

enthalten in: PLoS pathogens | 2023

von Leon-Icaza, S. | Bagayoko, S. | Vergé, R. | +24

4

Multimodality therapy for lung cancer invading the chest wall : A study of the French EPITHOR database

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Tricard, J. | Filaire, M. | Vergé, R. | +5

5

A 3D-engineered silicone stent to treat a refractory bronchopleural fistula

enthalten in: ERJ open research | 2023

von Roy, P. | Héluain, V. | Leyx, P. | +4

6

EEF2-inactivating toxins engage the NLRP1 inflammasome and promote epithelial barrier disruption uponPseudomonasinfection

enthalten in: bioRxiv.org | 2023

von Pinilla, M. | Mazars, R. | Vergé, R. | +16

7

Predictive factors and prognosis of microscopic residual disease in non-small-cell lung cancer surgery

enthalten in: European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery | 2022

von Rabinel, P. | Vergé, R. | Cazaux, M. | +4

1
[1]